Salvage transoral videolaryngoscopic surgery for post‐irradiation recurrence of hypopharyngeal carcinoma

  • Akihiro Sakai
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Koji Ebisumoto
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Hiroaki Iijima
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Mayu Yamauchi
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Takanobu Teramura
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Aritomo Yamazaki
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Takane Watanabe
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Toshihide Inagi
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Daisuke Maki
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan
  • Kenji Okami
    Department of Otolaryngology, Head and Neck Surgery Tokai University, School of Medicine Isehara Japan

書誌事項

公開日
2023-04-26
資源種別
journal article
権利情報
  • http://creativecommons.org/licenses/by-nc-nd/4.0/
DOI
  • 10.1002/lio2.1068
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Transoral salvage surgery has the potential to preserve a patient's quality of life. Therefore, we investigated the outcomes, safety, and risk factors for postoperative complications of salvage transoral videolaryngoscopic surgery (TOVS) for recurrent hypopharyngeal carcinoma after radiotherapy (RT) or chemoradiotherapy (CRT).</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This retrospective analysis enrolled patients with hypopharyngeal cancer who had a history of RT or CRT and underwent TOVS from January 2008 to June 2021. The factors related to postoperative complications, postoperative swallowing functions and survival rates were analyzed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Seven patients (36.8%) of the 19 patients developed complications. Severe dysphagia was the primary complication, and post‐cricoid resection was a complication risk factor. The FOSS score was significantly lower in the salvage treatment group. The survival rates were: 3‐year overall survival: 94.4%; disease‐specific survival: 94.4%; 5‐year overall survival: 62.3%; and disease‐specific survival: 86.6%.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Salvage TOVS for hypopharyngeal cancer was feasible, and oncologically and functionally reasonable.</jats:p><jats:p><jats:bold>Level of Evidence:</jats:bold> 2b.</jats:p></jats:sec>

収録刊行物

参考文献 (40)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ